EP2167038
USE OF TACI-IG FUSION PROTEIN SUCH AS ATACICEPT FOR THE MANUFACTURE OF A MEDICAMENT FOR TREATING LUPUS ERYTHEMATOSUS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
13.6.2008EP published:
25.4.2018EP application number:
08771043.0
EPO information:
European Patent Register
Max expiry date:
12.6.2028
Title:
USE OF TACI-IG FUSION PROTEIN SUCH AS ATACICEPT FOR THE MANUFACTURE OF A MEDICAMENT FOR TREATING LUPUS ERYTHEMATOSUS
Timeline
Today
13.6.2008EP application
25.4.2018EP Publication
Owner
Name:
Zymogenetics, Inc.Address:
1201 Eastlake Avenue East, 98102, Seattle, WA, US
Name:
ARES TRADING S.A.Address:
Zone Industrielle de l'Ouriettaz, 1170, Aubonne, CH
Inventor
Name:
BUSBY, Sharon J.Address:
Seattle, Washington, US
Name:
GROSS, Jane A.Address:
Seattle, Washington, US
Name:
VISICH, JenniferAddress:
San Francisco, CA, US
Name:
NESTOROV, IvanAddress:
Issaguah, Washington, US
Name:
MUNAFO, AlainAddress:
Tartegnin, CH
Name:
PAPASOULIOTIS, OrestisAddress:
Geneva, CH
Name:
PENA ROSSI, ClaudiaAddress:
Geneva, CH
Priority
Number:
943618 PDate:
13.6.2007Country:
US
Number:
24031Date:
28.1.2008Country:
US
Classification
Categories:
A61K 9/06, A61K 9/00, A61K 38/00